Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 131
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Hebrew University’ Yissum and Israeli Biotech Clearmind Medicine’s Psychedelic-Derived Obesity Treatment...
Small Pharma Reports Positive Top-line Results from Phase IIa Trial of...
GH Research Provides Business Updates and Highlights Key Upcoming Milestones
Small Pharma To Announce Results of SPL026 Phase IIa Trial for...
Diamond Therapeutics Announces Health Canada Approval of Phase 2 Clinical Trial...
Panel: Three Psychedelics Companies that Raised in 2022
PT383 – Identity, Rage, Culture, and Venture Capital
Panel: Psychedelic VCs Reflect on 2022
Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer
Psychedelic Funding in 2022
Load more